Galderma Laboratories L.Pal Revenue and Competitors

Claim your profile

Dallas, TX USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Galderma Laboratories L.Pal's estimated annual revenue is currently $62.5M per year.(i)
  • 0

Employee Data

    00
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.1M11020%N/AN/A
#2
$5.4M6523%N/AN/A
#3
$62.5M0N/AN/AN/A
#4
$3.9M4731%N/AN/A
#5
$3.2M170%$48.2MN/A
#6
$78.4M39019%N/AN/A
#7
$19.5M9759%N/AN/A
#8
$75.2M3741%N/AN/A
#9
$4.4M53-2%N/AN/A
#10
$5.8M2916%N/AN/A

CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company currently focused on providing innovative medical therapies to the dental and dermatology markets. The Company's lead product, Periostat, was approved by the FDA in September 1998 and is the first and only pharmaceutical to treat periodontal disease by inhibiting the enzymes that destroy periodontal support tissues.

keywords:N/A

N/A

Total Funding

N/A

Number of Employees

$62.5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Galderma Laboratories L.Pal News

2022-04-06 - Skincare Market Is Projected to Grow at A Robust CAGR of 8.1 ...

For instance, in 2021, Galderma Laboratories, L.P.-Cetaphil ... L.P., PDI, Inc., Betco Corporation, Pal International, PSK Pharma Pvt. Ltd.,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A1N/AN/A
#2
$0.2M2N/AN/A
#3
$1.7M2N/AN/A
#4
$0.4M3-50%N/A
#5
$0.4M3N/AN/A